Skip to main content
Full access
FROM THE EDITOR
Published Online: 1 July 2003

Posttraumatic Stress Disorder: A Serious Mental Illness

Just as schizophrenia and bipolar disorder are considered serious mental illnesses, so should posttraumatic stress disorder (PTSD), a condition whose prevalence in the United States exceeds the combined prevalences of these other two disorders. People who have PTSD can expect, on average, to endure over two decades of active symptoms and to miss almost 1 day of work per week. They have a 20% chance of attempting suicide, an outcome that is not fully explained by the presence of comorbid depression (1, 2). The destructive effect of PTSD on intimate attachments and sources of support is well recognized. Overall, PTSD imposes a heavy burden on the health care system (3).
Can PTSD be effectively treated? Until about 5 years ago, we had only a limited appreciation of how effective treatment could be. What little we knew led us to believe that gains were only modest and treatment largely palliative. More recent reports of trials assessing selective serotonin reuptake inhibitors and exposure-based psychosocial therapies have fortunately painted a much brighter picture, and it is now justifiable, indeed best practice, to think of remission as the desired outcome (4, 5). It is also important to keep in mind that most survivors of trauma do not develop PTSD. Could innate human resilience have a protective effect? Is it possible to promote resilience with our known effective treatments? Evidence suggests that this may be so (4). The articles presented in this edition of Focus serve as timely elaborations on these themes.

References

1.
Kessler RC: Posttraumatic stress disorder: the burden to the individual and society. J Clin Psychiatry 2000; 61(suppl 5):4–14
2.
Davidson JRT, Hughes DC, Blazer DG, George LK: Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 1991; 21:713–721
3.
Davidson JRT: Recognition and treatment of posttraumatic stress disorder. JAMA 2001; 286:584–588
4.
Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR: Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry 1999; 175:17–22
5.
Hembree EA, Foa EB: Posttraumatic stress disorder: psychological factors and psychosocial interventions. J Clin Psychiatry 2000; 61(suppl 7):33–39

Information & Authors

Information

Published In

History

Published online: 1 July 2003
Published in print: July 2003

Authors

Affiliations

Jonathan R. T. Davidson, M.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share